Chemo India Formulation Private Limited - Due diligence report

A 360° intelligence report on Chemo India Formulation Private Limited: trust score, financial health, credit view, compliance, directors, gr…

2015-08-13 Hyderabad, Telangana Active Unlisted Active Compliant
Share
View plans Plan
CI Chemo India Formulation Private Limited
View plans Plan
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Chemo India Formulation Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
83/100
Trust Score
Low Risk

Chemo India Formulation Private Limited is assessed as Low Risk with a Trust Score of 83/100. Chemo India Formulation Private Limited is an active private limited foreign company incorporated in india incorporated in 2015, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 14 Jul 2026 from the latest processed filings. Chemo India Formulation Private Limited snapshot & full profile →

Financial Health › Neutral
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
83/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
50/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
60/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
85/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 60/100 Moderate
  • No open charges - unencumbered balance sheet.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
MARIA SANDRA MARTIN MORAN 01234567 Director 01/04/2018 6 yrs Approved
SATHEESH RAO PONUGOTI 01234567 Director 01/04/2018 6 yrs Approved
BHARAT VASUDEVAN 01234567 Director 01/04/2018 6 yrs Approved
MANUEL IGNACIO BARRO 01234567 Director 01/04/2018 6 yrs Approved
RAMACHANDRA KUMAR KURUMADDALI 01234567 Director 01/04/2018 6 yrs Approved
  • 5 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2025)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2025 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Chemo Holdings Sl
Subsidiaries
-
Group entities
-
Capital events
16 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Chemo Holdings Sl Holding Company 74.00%

Key managerial personnel: RAMACHANDRA KUMAR KURUMADDALI (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 85 · Distress 75
Growth signals & trust indicators
Revenue acceleration: +38% over 4 year(s).
Latest year revenue grew 1.42.
EPFO headcount growing - hiring signal.
Operating for 10+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Losses deepening year-on-year.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence87/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment67/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view72/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 3 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
27 Sep 2021
Director ceased
RAMACHANDRA KUMAR KURUMADDALI
30 Sep 2019
Director ceased
BHARAT VASUDEVAN
Director ceased
MANUEL IGNACIO BARRO
06 Jun 2019
Director appointed
BHARAT VASUDEVAN (Director)
Director appointed
MANUEL IGNACIO BARRO (Director)
18 Jan 2019
Securities allotted
6956665 Equity Shares - 6.96 cr raised
Securities allotted
12925725 Equity Shares - 12.93 cr raised
Securities allotted
4025700 Equity Shares - 4.03 cr raised
05 Nov 2018
Securities allotted
3599568 Equity Shares - 3.60 cr raised
07 Sep 2018
Securities allotted
6799533 Equity Shares - 6.80 cr raised
13 Jun 2018
Securities allotted
12360769 Equity Shares - 12.36 cr raised
31 Mar 2018
Securities allotted
6405231 Equity Shares - 6.41 cr raised
05 Jan 2018
Securities allotted
7577861 Equity Shares - 7.58 cr raised
10

Key Observations

Auto-generated from the data above
Revenue grew 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
5 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2025 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 16 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Process Combustion Technologies India Private Limited U72900DL2020PTC363045 New Delhi, Delhi, India
Rti International U73100DL2014FTC272748 New Delhi, Delhi, India
Take Solutions L63090TN2000PLC046338 Chennai, Tamil Nadu, India
Escientia Lifesciences U24100TG2008PTC057277 Hyderabad, Telangana, India
Perfect Day U73100KA2019PTC130106 Anekal, Karnataka, India
Lyruslife U24230KA2015PTC080902 Bangalore, Karnataka, India
Selp India Private Limited U51495DL2013FTC258740 New Delhi, Delhi, India
Amway U74110DL2018FTC336447 New Delhi, Delhi, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Chemo India Formulation Private Limited before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Chemo India Formulation Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 60/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 85/100, margin trends, ownership structure and peer set for Chemo India Formulation Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 83/100, distress signals and MSME payment-delay disclosures - know whether Chemo India Formulation Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Chemo India Formulation Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Chemo India Formulation Private Limited an active company?

Chemo India Formulation Private Limited has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Chemo India Formulation Private Limited financially healthy?

Chemo India Formulation Private Limited has a Financial Health Score of 50/100 (Moderate) based on its filed financial statements.

Should I do business with Chemo India Formulation Private Limited?

Its overall Trust Score is 83/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Chemo India Formulation Private Limited?

The ultimate holding entity is Chemo Holdings Sl. 5 active director(s) are on record.

Does Chemo India Formulation Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Chemo India Formulation Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Chemo India Formulation Private Limited?

Its Credit Risk Score is 60/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.